obesity drug news - Search News

Amgen, obesity

Amgen Obesity Drug More Effective Than Competitors

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

CNBC on MSN · 2d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Investor's Business Daily on MSN · 1d

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen stock tumbled Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's Zepbound.

Biden, obesity and Medicaid

ABC News on MSN · 1d

Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

The Hill · 2d

Biden proposes anti-obesity drug rule

Click in for more news from The Hill{beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover obesity drugsA proposed rule from the Biden administration

USA Today · 1d

Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

Health Canada approves obesity drug Wegovy

Reuters · 1d

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish drugmaker said on Wednesday.

MarketWatch · 1d

Health Canada approves Wegovy(R) (semaglutide injection) to reduce the risk of non-fatal myocardial infarction

Wegovy(R) is the first-and-only medication indicated for both chronic weight management and to reduce the risk of non-fatal myocardial infarction (MI) in Canada.1 -- Close to one in three Canadian adults are living with obesity,

cbc.ca on MSN · 2h

Health Canada approves obesity drug Wegovy as a way to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

1don MSN

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

BioPharma Dive2d

Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential ...

2dOpinion

White House rule would expand coverage of anti-obesity drugs

It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight ...

New Drug Causes 20 Percent Weight Loss in Early Amgen Results

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

McKnight's Long-Term Care News1d

CMS’ obesity drug coverage implications for nursing home patients

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

1don MSN

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations

The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...

STAT3d

Pharmalittle: We’re reading about Trump’s FDA pick, problems with a Merck asthma drug, and more

Martin Makary, President-elect Trump’s pick to run the U.S. Food and Drug Administration ... in the middle of a fight ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results